Oli Denne

Oli is a senior associate in our Cambridge office and is part of the Corporate Technology team.

Oli advises a range of companies in the tech and life sciences sectors on a variety of corporate matters, including venture capital investments, fundraisings, M&A and joint ventures.

CV ansehen CV ausblenden

Karriere

Since 2023	Senior Associate, Taylor Wessing
2021 - 2023	Associate, Taylor Wessing
2019 - 2020	Associate, Slaughter and May

2017 - 2019

Trainee solicitor, Slaughter and May

Mehr Weniger

Ausbildung

2019	Admitted as a solicitor in England & Wales
2016 - 2017	GDL & LPC, BPP Law School
2012 - 2015	BA Politics, University of Warwick

Expertise

Rechtsgebiete und Gruppen Gesellschaftsrecht/ M&A & Kapitalmärkte Venture Capital M&A

Branchen Technology, Media & Communications Life Sciences & Healthcare

Experience

Apollo Therapeutics closes $226.5 million series C financing

We advised Apollo Therapeutics in their USD226.5 million series C fundraising. Apollo aims to advance pipeline programs through clinical development and further fund the company’s drug discovery and development activities based on breakthroughs in basic medical research made at its partner institutions, which include The Institute of Cancer Research.

Press release

Andrew Edge

Howard Palmer

Oli Denne

Gesamtes Team ansehen Team ausblenden

Aktuelle News & Insights